Publications by authors named "Mark Feneley"

Claim this Profile
R
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Wei Shen Tan, Anesh Panchal, Laura Buckley, Adam J Devall, Laurence S Loubière, Mark R Feneley

Eur Urol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes.
Malcolm Carruthers, Paul Cathcart, Mark R Feneley

Aging Male· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia.
Wei Shen Tan, Simon Rodney, Benjamin Lamb, Mark Feneley, John Kelly

Cancer Treat Rev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue.
Andrew J Symes, Marte Eilertsen, Michael Millar, Joseph Nariculam, Alex Freeman, Mark R Feneley

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic diagnostic cystoscopy.
Ashoke Roy, Pallavi Pal, Manit Arya, Raj Persad, John D Kelly, Mark R Feneley

BJU Int· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is testosterone treatment good for the prostate? Study of safety during long-term treatment.
Mark R Feneley, Malcolm Carruthers

J Sex Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International web survey shows high prevalence of symptomatic testosterone deficiency in men.
Tom R Trinick, Mark R Feneley, Hugh Welford, Malcolm Carruthers

Aging Male· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance and therapeutic implications of extraprostatic invasion.
Charlotte L Foley, Mark R Feneley

Surg Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer. Preface.
Mark R Feneley

Surg Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of prostate cancer treatment.
Seshadri Sriprasad, Mark R Feneley, Peter M Thompson

Surg Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
Joseph Nariculam, Alex Freeman, Simon Bott, Phillipa Munson, Noriko Cable, Mark Feneley

Asian J Androl· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer: diagnosis and staging.
Nigel Borley, Mark R Feneley

Asian J Androl· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Jas Kalsi, Stephen J Harland, Mark R Feneley

Expert Opin Drug Deliv· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse.
Nicola Brookman-Amissah, Joseph Nariculam, Alex Freeman, Magali Willamson, Roger S Kirby, Mark R Feneley

Cancer Genet Cytogenet· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plexin-B1 mutations in prostate cancer.
Oscar Gee-Wan Wong, Tharani Nitkunan, Izumi Oinuma, Chun Zhou, Veronique Blanc, Mark R Feneley

Proc Natl Acad Sci U S A· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen testing in hypogonadism: implications for the safety of testosterone-replacement therapy.
Duncan C Gould, Mark R Feneley, Roger S Kirby

BJU Int· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon.
Masahiko Harada, Josephine Woodhams, Alexander J MacRobert, Mark R Feneley, Harubumi Kato

J Photochem Photobiol B· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics.
István Laczkó, David L Hudson, Alex Freeman, Mark R Feneley, John R Masters

Prostate· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phased-array MRI of canine prostate using endorectal and endourethral coils.
Andrew C Yung, Ali Y Oner, Jean-Michel Serfaty, Mark Feneley, Xiaoming Yang

Magn Reson Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis